| 000 | 01239 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515073723.0 | ||
| 264 | 0 | _c20070907 | |
| 008 | 200709s 0 0 ger d | ||
| 022 | _a1438-3276 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrüger, Klaus | |
| 245 | 0 | 0 |
_a[3 questions about gastrointestinal risk. Are coxibs here clearly better than NSAID?]]. _h[electronic resource] |
| 260 |
_bMMW Fortschritte der Medizin _cNov 2006 |
||
| 300 |
_a12 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Interview | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aDiclofenac _xadverse effects |
| 650 | 0 | 4 | _aEtoricoxib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteoarthritis _xdrug therapy |
| 650 | 0 | 4 |
_aPeptic Ulcer _xchemically induced |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPyridines _xadverse effects |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aSulfones _xadverse effects |
| 773 | 0 |
_tMMW Fortschritte der Medizin _gvol. 148 _gno. 48 _gp. 12 |
|
| 999 |
_c17151471 _d17151471 |
||